اقتصاد
اقتصاد
Ready to play
Ready to play
Iran is facing an increasing crisis in securing medicines due to the blockade and sanctions, which have caused the prices of most drugs to rise between 100% and 1000%, and led to shortages of certain types, especially for chronic diseases. The blockade makes it difficult to import pharmaceutical materials and increases shipping costs, forcing patients to seek alternatives or purchase only essential items, which negatively impacts their health. Nonetheless, health authorities confirm that Iran produces more than 85% of its pharmaceutical needs and is trying to secure medicines through alternative channels. However, the declining purchasing power of citizens and recent conflicts have worsened the suffering of patients and affected the stability of the healthcare sector.
Notice: This Is an AI-Generated Summary
Comments (0)